Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy.
adjuvant chemotherapy
dose-dense chemotherapy
early breast cancer
gene signature
lymph node-positive
Journal
Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
revised:
16
11
2022
received:
01
06
2022
accepted:
13
04
2023
medline:
12
6
2023
pubmed:
15
4
2023
entrez:
14
4
2023
Statut:
ppublish
Résumé
The utility of multigene expression assays in advanced (≥ 4 positive lymph nodes) early breast cancer (EBC) is limited. We conducted exploratory transcriptomic analysis of 758 genes (Breast Cancer 360 panel, nCounter
Identifiants
pubmed: 37057719
doi: 10.1002/1878-0261.13435
pmc: PMC10257423
doi:
Substances chimiques
Biomarkers, Tumor
0
Receptor, ErbB-2
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1060-1075Informations de copyright
© 2023 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
Br J Cancer. 2006 May 8;94(9):1237-44
pubmed: 16622463
J Transl Med. 2018 Apr 4;16(1):87
pubmed: 29615063
Ann Oncol. 2014 Aug;25(8):1544-50
pubmed: 24608200
J Clin Oncol. 2013 Mar 1;31(7):860-7
pubmed: 23341518
DNA Cell Biol. 2020 May;39(5):864-874
pubmed: 32181676
Int J Cancer. 2020 Jul 1;147(1):160-169
pubmed: 31724170
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Int J Cancer. 2020 Jan 1;146(1):262-271
pubmed: 31162838
Cancer. 2020 Mar 15;126(6):1175-1182
pubmed: 31851385
J Immunother Cancer. 2018 Jun 22;6(1):63
pubmed: 29929551
Lancet. 2019 Apr 6;393(10179):1440-1452
pubmed: 30739743
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
Eur J Cancer. 2019 Jun;114:76-88
pubmed: 31075727
Front Med (Lausanne). 2018 Sep 04;5:248
pubmed: 30234119
Clin Cancer Res. 2019 Sep 15;25(18):5717-5726
pubmed: 31227501
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
J Clin Oncol. 2009 Mar 10;27(8):1168-76
pubmed: 19204205
Int J Cancer. 2013 Jun 1;132(11):2537-47
pubmed: 23136075
Nat Clin Pract Oncol. 2006 Aug;3(8):406-7
pubmed: 16894366
NPJ Breast Cancer. 2016;2:
pubmed: 28691057
Breast Cancer Res Treat. 2013 Apr;138(2):457-66
pubmed: 23423445
Clin Cancer Res. 2020 Jun 1;26(11):2603-2614
pubmed: 32005747
N Engl J Med. 2016 Aug 25;375(8):717-29
pubmed: 27557300
Ann Oncol. 2015 Aug;26(8):1698-704
pubmed: 25995301
NPJ Breast Cancer. 2020 Mar 6;6:8
pubmed: 32195331
BMC Med Genomics. 2015 Aug 22;8:54
pubmed: 26297356
Biosci Rep. 2020 Jul 31;40(7):
pubmed: 32602545
Breast. 2015 Nov;24 Suppl 2:S26-35
pubmed: 26253814
Hum Pathol. 2016 Jan;47(1):78-84
pubmed: 26541326
Ann Oncol. 2019 Jul 1;30(7):1044-1050
pubmed: 31131397
J Natl Cancer Inst. 2016 Oct 13;109(1):
pubmed: 27737921
Cancer Cell. 2015 Dec 14;28(6):690-714
pubmed: 26678337
Breast Cancer Res Treat. 2015 Jan;149(2):439-48
pubmed: 25552364
Breast Cancer Res Treat. 2015 Jun;151(2):251-9
pubmed: 25917869
J Clin Oncol. 2015 Mar 20;33(9):983-91
pubmed: 25534375
Br J Cancer. 2020 May;122(11):1611-1617
pubmed: 32231293
NPJ Breast Cancer. 2019 Apr 18;5:15
pubmed: 31016233
Ann Oncol. 2019 Dec 1;30(12):1941-1949
pubmed: 31566659
N Engl J Med. 2007 Oct 11;357(15):1496-506
pubmed: 17928597
Breast Care (Basel). 2019 Jun;14(3):159-164
pubmed: 31316314
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190